Takayama Shun, Dohi Osamu, Horie Ryusuke, Yasuda Takeshi, Ochiai Tomoko, Iwai Naoto, Imamoto Eiko, Takagi Tomohisa, Handa Osamu, Konishi Hideyuki, Ando Takashi, Naito Yuji, Takemura Toshiki, Itoh Yoshito
Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 6028566, Japan.
Department of Gastroenterology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto 6038151, Japan.
Diagnostics (Basel). 2025 Sep 18;15(18):2376. doi: 10.3390/diagnostics15182376.
: This study aimed to identify specific endoscopic findings associated with the development of GC following successful eradication. : This prospective multicenter observational study included patients who underwent annual surveillance endoscopy after successful eradication therapy between September 2013 and June 2019. Endoscopic findings were evaluated one year after eradication therapy and analyzed using the Kyoto Classification of Gastritis to identify factors associated with GC development. : A total of 465 patients were included, including 49 patients with GC and 416 patients without GC. At the initial endoscopic assessment (median, 0.96 years post-eradication), emergence of map-like redness and invisible regular arrangement of collecting venule (RAC) as independent predictors of GC (map-like redness: hazard ratio [HR], 2.561; 95% confidence interval [CI], 1.362-4.572; = 0.003; invisible RAC: HR, 3.131; 95% CI, 1.078-9.091; = 0.036). Patients with map-like redness or invisible RAC showed a significantly higher incidence of GC than those without map-like redness or invisible RAC ( < 0.001 and < 0.001, respectively). Notably, map-like redness and visible RAC appeared in 13% and 28.4% of cases within the first year after eradication, respectively. : Map-like redness and invisible RAC were identified as independent predictors of GC following eradication and may serve as early predictive indicators, appearing within one year of successful eradication. This finding underscores the importance of early surveillance endoscopy in identifying patients at elevated risk for GC.
本研究旨在确定成功根除幽门螺杆菌后与胃癌发生相关的特定内镜检查结果。本前瞻性多中心观察性研究纳入了2013年9月至2019年6月期间接受成功根除治疗后每年进行一次监测内镜检查的患者。在根除治疗一年后评估内镜检查结果,并使用京都胃炎分类法进行分析,以确定与胃癌发生相关的因素。共纳入465例患者,其中49例患有胃癌,416例未患胃癌。在初次内镜评估时(根除后中位数为0.96年),地图样发红和集合小静脉不可见的规则排列(RAC)被确定为胃癌的独立预测因素(地图样发红:风险比[HR],2.561;95%置信区间[CI],1.362 - 4.572;P = 0.003;不可见RAC:HR,3.131;95% CI,1.078 - 9.091;P = 0.036)。有地图样发红或不可见RAC的患者胃癌发生率显著高于无地图样发红或不可见RAC的患者(分别为P < 0.001和P < 0.001)。值得注意的是,根除后第一年内分别有13%和28.4%的病例出现地图样发红和可见RAC。地图样发红和不可见RAC被确定为根除幽门螺杆菌后胃癌的独立预测因素,可能作为早期预测指标,在成功根除后一年内出现。这一发现强调了早期监测内镜检查在识别胃癌高危患者中的重要性。